"It's all the time in my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting

被引:71
|
作者
Watt, Melissa H. [1 ]
Maman, Suzanne [2 ]
Earp, Jo Anne [2 ]
Eng, Eugenia [2 ]
Setel, Philip W. [3 ]
Golin, Carol E. [2 ]
Jacobson, Mark [4 ]
机构
[1] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA
[2] Univ N Carolina, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC 27515 USA
[3] Bill & Melinda Gates Fdn, Seattle, WA USA
[4] Selian Lutheran Hosp, Arusha, Tanzania
关键词
Tanzania; Africa; HIV; Antiretroviral therapy; Adherence; MEDICATION ADHERENCE; BARRIERS; PREDICTORS; HIV/AIDS; ACCESS; WOMEN;
D O I
10.1016/j.socscimed.2009.02.037
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although HIV positive patients' adherence to antiretroviral therapy (ART) is relatively high in African nations, as compared with industrialized nations, few studies have explored why. In the research presented here we aimed to understand the dynamics of good adherence to ART among patients receiving free ART and HIV-related services from a clinic in Arusha, Tanzania. We conducted individual semi-structured interviews with 6 health care providers and 36 patients at a health care center in Arusha in 2006. Interviews were conducted in Swahili using interview guides informed by social cognitive theory. All interviews were audio-recorded, transcribed in Kiswahili, translated into English and coded for themes and patterns with ATLAS.ti. Of the 36 patients interviewed (mean time on ART 9.8 months; range 1-23 months), 32 reported perfect adherence in the previous month. Self-reported adherence was high despite economic hardship, depression, low rates of HIV disclosure and high perceived HIV-associated stigma. Five factors emerged to explain excellent adherence in the face of such barriers. First, all respondents experienced substantial improvements in their health after starting ART: this supported their confidence in the medication and motivated them to adhere. Second, their perceived need to be able to meet their family responsibilities motivated respondents to stay healthy. Third, respondents developed specific strategies to remember to take pills, particularly routinizing pill-taking by linking it with daily activities or events. Fourth, material and emotional support received from others facilitated adherence. Finally, respondents trusted the advice and instructions of their health care providers, who regularly emphasized adherence. The facilitating factors identified were consistent with the constructs of social cognitive theory and highlighted the importance of interventions that address multiple levels of influence on adherence. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1793 / 1800
页数:8
相关论文
共 50 条
  • [31] Opinions of a Small Sample of Pharmacists About Pharmacy Setting and Patient Adherence to Antiretroviral Therapy
    Kibicho, Jennifer
    Owczarzak, Jill
    Pinkerton, Steven D.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2012, 18 (06): : 446 - 452
  • [32] Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare
    Christine Tapp
    M-J Milloy
    Thomas Kerr
    Ruth Zhang
    Silvia Guillemi
    Robert S Hogg
    Julio Montaner
    Evan Wood
    [J]. BMC Infectious Diseases, 11
  • [33] Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare
    Tapp, Christine
    Milloy, M-J
    Kerr, Thomas
    Zhang, Ruth
    Guillemi, Silvia
    Hogg, Robert S.
    Montaner, Julio
    Wood, Evan
    [J]. BMC INFECTIOUS DISEASES, 2011, 11
  • [34] DOSE OF INTERVENTION, ADHERENCE TO ANTIRETROVIRAL THERAPY, AND HEALTH OUTCOMES OVER TIME
    Erlen, Judith A.
    Sereika, Susan M.
    Caruthers, Donna D.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S92 - S92
  • [35] Adherence to antiretroviral therapy, virological response, and time to resistance in the Dakar cohort
    Tournoud, M.
    Etard, J. F.
    Ecochard, R.
    DeGruttola, V.
    [J]. STATISTICS IN MEDICINE, 2010, 29 (01) : 14 - 32
  • [36] Modality of Primary HIV Disclosure and Association with Mental Health, Stigma, and Antiretroviral Therapy Adherence in Tanzanian Youth Living with HIV
    Ramos, Julia V.
    Mmbaga, Blandina T.
    Turner, Elizabeth L.
    Rugalabamu, Leonia L.
    Luhanga, Severa
    Cunningham, Coleen K.
    Dow, Dorothy E.
    [J]. AIDS PATIENT CARE AND STDS, 2018, 32 (01) : 31 - 37
  • [37] Barriers and facilitators for adherence to antiretroviral therapy, and strategies to address the barriers in key populations, Mumbai-A qualitative study
    Acharya, Shrikala
    Parthasarathy, Mugundu Ramien
    Karanjkar, Vijaykumar
    Katkar, Sachendra
    Setia, Maninder Singh
    [J]. PLOS ONE, 2024, 19 (07):
  • [38] Barriers and facilitators to adherence for antiretroviral therapy: the perspectives of patients from a wellness center in the Mpumalanga Province, South Africa
    Simelane, Portia
    Simelane, Maswati S.
    Amoateng, Acheampong Y.
    [J]. AFRICAN HEALTH SCIENCES, 2022, 22 (03) : 455 - 462
  • [39] Barriers and facilitators to antiretroviral therapy adherence among patients with HIV in Bissau, Guinea-Bissau: A qualitative study
    Rasmussen, Dlama N.
    Te, David da Silva
    Rodkjaer, Lotte
    Oliveira, Ines
    Medina, Candida
    Barfod, Toke
    Laursen, Alex L.
    Aaby, Peter
    Sodemann, Morten
    Wejse, Christian
    [J]. AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2013, 12 (01): : 1 - 8
  • [40] Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa
    Coetzee, D
    Boulle, A
    Hildebrand, K
    Asselman, V
    Van Cutsem, G
    Goemaere, E
    [J]. AIDS, 2004, 18 : S27 - S31